SOLID TUMORS
Clinical trials for SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMORS trials appear
Sign up with your email to follow new studies for SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug combo trial halted early
Disease control TerminatedThis early-stage study tested an experimental drug called ABBV-303, alone or with another drug (budigalimab), in adults with advanced solid tumors that had stopped responding to treatment. The goal was to check safety and see if the drugs could shrink tumors. The study was termin…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated May 16, 2026 23:49 UTC
-
Promising cancer drug trial halted early – what we know
Disease control TerminatedThis study tested a new pill, BI 907828, in adults with advanced cancers of the bile duct, pancreas, lung, or bladder that have a specific genetic change (MDM2 amplification). The goal was to see if the drug could shrink tumors. The study was stopped early, but the results may st…
Matched conditions: SOLID TUMORS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New cancer drug trial seeks safer doses for tough tumors
Disease control TerminatedThis study tested a new drug called INCB057643 in 137 people with advanced solid tumors or blood cancers that had stopped responding to other treatments. The goal was to find a safe dose and see if the drug could control the disease when used alone or with standard cancer medicin…
Matched conditions: SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New cancer drug combo tested, but study halted early
Disease control TerminatedThis early-phase study tested a new drug called LY3127804, given alone or with another drug (ramucirumab), in 62 people with advanced solid tumors. The main goal was to check safety and find the right dose. The study was stopped early, and the best dose was not determined.
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 13, 2026 16:05 UTC
-
Cancer cocktail study halted: early hopes dashed for Triple-Drug combo
Disease control TerminatedThis study tested a combination of three drugs (azacitidine, pembrolizumab, and epacadostat) in people with advanced solid tumors, including lung and colorectal cancers that had stopped responding to standard treatments. The goal was to see if the combination was safe and could s…
Matched conditions: SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Pfizer's experimental cancer drug trial halted early
Disease control TerminatedThis early-stage study tested a new drug called PF-08046031 in 11 adults with advanced melanoma or other solid tumors that had spread or no longer responded to standard treatments. The main goal was to check the drug's safety and side effects. The study was terminated early, so r…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Experimental cancer drug tested in advanced tumors – study halted early
Disease control TerminatedThis early-stage study tested an experimental drug called INCB062079 in 25 people with advanced liver cancer (hepatocellular carcinoma) and several other solid tumors. The main goal was to check the drug's safety and find the highest dose people could tolerate. The study was term…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Early-Stage cancer drug trial halted after just 3 patients
Disease control TerminatedThis early-phase study tested a new oral drug, INCB086550, in Japanese adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was terminated early and only enrolled 3 participants, so n…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Experimental cancer drug study halted early after only 3 patients
Knowledge-focused TerminatedThis study looked at how the body absorbs, breaks down, and gets rid of the experimental drug subasumstat in adults with advanced solid tumors that had no other treatment options. Only 3 people took part before the study was stopped early. The main goal was to measure the drug an…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 16, 2026 23:47 UTC